Isolation of a bacteriophage and its depolymerase specific for K1 capsule of klebsiella pneumoniae: Implication in typing and treatment

Journal of Infectious Diseases

Volumn 210, Issue 11, 2014, Pages 1734-1744

  Lin, Tzu Lung ^a   Hsieh, Pei Fang ^a   Huang, Yu Tsung ^b   Lee, Wei Ching ^a   Tsai, Yi Ting ^a   Su, Po An ^a   Pan, Yi Jiun ^a   Hsu, Chun Ru ^a   Wu, Meng Chuan ^a   Wang, Jin Town ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Capsule; Capsule depolymerase; Klebsiella pneumoniae; Phage

Indexed keywords

BACTERIAL ENZYME; DEPOLYMERASE; ORF34 PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; BETA LACTAMASE; BETA-LACTAMASE K1; CAPSULAR-POLYSACCHARIDE GALACTOHYDROLASE; CYTOKINE; GLYCOSIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CAPSULE; BACTERIAL CLEARANCE; BACTERIAL COUNT; BACTERIAL STRAIN; BACTERIOPHAGE; BACTERIOPHAGE TYPING; CONTROLLED STUDY; ENZYME SPECIFICITY; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING KLEBSIELLA PNEUMONIAE; FEMALE; GENE SEQUENCE; GENETIC SIMILARITY; GENOME ANALYSIS; INNATE IMMUNITY; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; STRAIN IDENTIFICATION; SYNTENY; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS ISOLATION; ABSCESS; ANIMAL; BACTERIUM IDENTIFICATION; CLASSIFICATION; DISEASE MODEL; ENZYMOLOGY; GENE DELETION; GENE EXPRESSION; GENE ORDER; GENETICS; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTIONS; METABOLISM; MICROBIOLOGY; MORTALITY; VIRAL TROPISM; VIROLOGY;

ABSCESS; ANIMALS; BACTERIAL CAPSULES; BACTERIAL TYPING TECHNIQUES; BACTERIOPHAGES; BETA-LACTAMASES; CLONING, MOLECULAR; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GENE DELETION; GENE EXPRESSION; GENE ORDER; GENOME, VIRAL; GLYCOSIDE HYDROLASES; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICE; OPEN READING FRAMES; VIRAL TROPISM;

EID: 84921902484     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu332     Document Type: Article

References (44)

1. Anstey JR, Fazio TN, Gordon DL, et al. Community-acquired Klebsiella pneumoniae liver abscesses-an "emerging disease" in Australia. Med J Aust 2010; 193:543-5.
2. Chang SC, Fang CT, Hsueh PR, Chen YC, Luh KT Klebsiella pneumoniae isolates causing liver abscess in Taiwan. Diagn Microbiol Infect Dis 2000; 37:279-84.
3. Chung DR, Lee SS, Lee HR, et al. Emerging invasive liver abscess caused by K1 serotype Klebsiella pneumoniae in Korea. J Infect 2007; 54:578-83.
4. Li J, Fu Y, Wang JY, et al. Early diagnosis and therapeutic choice of Klebsiella pneumoniae liver abscess. Front Med China 2010; 4:308-16.
5. Liew KV, Lau TC, Ho CH, et al. Pyogenic liver abscess - a tropical centre's experience in management with review of current literature. Singapore Med J 2000; 41:489-92.
6. Lok KH, Li KF, Li KK, Szeto ML. Pyogenic liver abscess: clinical profile, microbiological characteristics, and management in a Hong Kong hospital. J Microbiol Immunol 2008; 41:483-90.
7. Moore R, O'Shea D, Geoghegan T, Mallon PW, Sheehan G. Community-acquired Klebsiella pneumoniae liver abscess: an emerging infection in Ireland and Europe. Infection 2013; 41:681-6.
8. Rahimian J, Wilson T, Oram V, Holzman RS. Pyogenic liver abscess: recent trends in etiology and mortality. Clin Infect Dis 2004; 39:1654-9.
9. Cheng NC, Yu YC, Tai HC, et al. Recent trend of necrotizing fasciitis in Taiwan: focus on monomicrobial Klebsiella pneumoniae necrotizing fasciitis. Clin Infect Dis 2012; 55:930-9.
10. Decre D, Verdet C, Emirian A, et al. Emerging severe and fatal infections due to Klebsiella pneumoniae in two university hospitals in France. J Clin Microbiol 2011; 49:3012-4.
11. Lin YT, Jeng YY, Chen TL, Fung CP. Bacteremic community-acquired pneumonia due to Klebsiella pneumoniae: clinical and microbiological characteristics in Taiwan, 2001-2008. BMC Infect Dis 2010; 10:307.
12. Siu LK, Yeh KM, Lin JC, Fung CP, Chang FY. Klebsiella pneumoniae liver abscess: a new invasive syndrome. Lancet Infect Dis 2012; 12:881-7.
13. Fung CP, Chang FY, Lee SC, et al. A global emerging disease of Klebsiella pneumoniae liver abscess: is serotype K1 an important factor for complicated endophthalmitis? Gut 2002; 50:420-4.
14. Fang CT, Chuang YP, Shun CT, Chang SC, Wang JT. A novel virulence gene in Klebsiella pneumoniae strains causing primary liver abscess and septic metastatic complications. J Exp Med 2004; 199:697-705.
15. Chuang YP, Fang CT, Lai SY, Chang SC, Wang JT. Genetic determinants of capsular serotype K1 of Klebsiella pneumoniae causing primary pyogenic liver abscess. J Infect Dis 2006; 193:645-54.
16. + Klebsiella pneumoniae in North America. J Clin Microbiol 2005; 43:991-2.
17. Keynan Y, Karlowsky JA, Walus T, Rubinstein E. Pyogenic liver abscess caused by hypermucoviscous Klebsiella pneumoniae. Scand J Infect Dis 2007; 39:828-30.
18. Kohayagawa Y, Nakao K, Ushita M, et al. Pyogenic liver abscess caused by Klebsiella pneumoniae genetic serotype K1 in Japan. J Infect Chemother 2009; 15:248-51.
19. Sachdev DD, Yin MT, Horowitz JD, Mukkamala SK, Lee SE, Ratner AJ. Klebsiella pneumoniae K1 liver abscess and septic endophthalmitis in a U.S. resident. J Clin Microbiol 2013; 51:1049-51.
20. Pan YJ, Fang HC, Yang HC, et al. Capsular polysaccharide synthesis regions in Klebsiella pneumoniae serotype K57 and a new capsular serotype. J Clin Microbiol 2008; 46:2231-40.
21. Yu WL, Ko WC, Cheng KC, Lee CC, Lai CC, Chuang YC. Comparison of prevalence of virulence factors for Klebsiella pneumoniae liver abscesses between isolates with capsular K1/K2 and non-K1/K2 serotypes. Diagn Microbiol Infect Dis 2008; 62:1-6.
22. Drulis-Kawa Z, Mackiewicz P, Kesik-Szeloch A, et al. Isolation and characterisation of KP34 - a novel phiKMV-like bacteriophage for Klebsiella pneumoniae. Appl Microbiol Biotechnol 2011; 90:1333-45.
23. Pieroni P, Rennie RP, Ziola B, Deneer HG. The use of bacteriophages to differentiate serologically cross-reactive isolates of Klebsiella pneumoniae. J Med Microbiol 1994; 41:423-9.
24. Liang K-Y, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73:13-22.
25. Lin TL, Yang FL, Yang AS, et al. Amino acid substitutions of MagA in Klebsiella pneumoniae affect the biosynthesis of the capsular polysaccharide. PLoS One 2012; 7:e46783.
26. Kong X, Hellermann GR, Patton G, et al. An immunocompromised BALB/c mouse model for respiratory syncytial virus infection. Virol J 2005; 2:3.
27. Humphries JC. Enzymic activity of bacteriophage-culture lysates: I. A capsule lysin active against Klebsiella pneumoniae type A. J Bacteriol 1948; 56:683-93.
28. Hsieh PF, Lin TL, Lee CZ, Tsai SF, Wang JT. Serum-induced iron-acquisition systems and TonB contribute to virulence in Klebsiella pneumoniae causing primary pyogenic liver abscess. J Infect Dis 2008; 197:1717-27.
29. Bastias R, Higuera G, Sierralta W, Espejo RT. A new group of cosmopolitan bacteriophages induce a carrier state in the pandemic strain of Vibrio parahaemolyticus. Environ Microbiol 2010; 12:990-1000.
30. Mushtaq N, Redpath MB, Luzio JP, Taylor PW. Prevention and cure of systemic Escherichia coli K1 infection by modification of the bacterial phenotype. Antimicrob Agents Chemother 2004; 48:1503-8.
31. Rakieten ML, Eggerth AH, Rakieten TL. Studies with bacteriophages active against mucoid strains of bacteria. J Bacteriol 1940; 40:529-45.
32. Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis 2011; 53:60-7.
33. Lin TL, Tang SI, Fang CT, Hsueh PR, Chang SC, Wang JT. Extended-spectrum beta-lactamase genes of Klebsiella pneumoniae strains in Taiwan: recharacterization of shv-27, shv-41, and tem-116. Microb Drug Resist 2006; 12:12-5.
34. Kang CI, Kim SH, Bang JW, et al. Community-acquired versus nosocomial Klebsiella pneumoniae bacteremia: clinical features, treatment outcomes, and clinical implication of antimicrobial resistance. J Korean Med Sci 2006; 21:816-22.
35. Su SC, Siu LK, Ma L, et al. Community-acquired liver abscess caused by serotype K1 Klebsiella pneumoniae with CTX-M-15-type extended-spectrum beta-lactamase. Antimicrob Agents Chemother 2008; 52:804-5.
36. Chhibber S, Kaur S, Kumari S. Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in mice. J Med Microbiol 2008; 57:1508-13.
37. Hung CH, Kuo CF, Wang CH, Wu CM, Tsao N. Experimental phage therapy in treating Klebsiella pneumoniae-mediated liver abscesses and bacteremia in mice. Antimicrob Agents Chemother 2011; 55:1358-65.
38. Kumari S, Harjai K, Chhibber S. Bacteriophage versus antimicrobial agents for the treatment of murine burn wound infection caused by Klebsiella pneumoniae B5055. J Med Microbiol 2011; 60:205-10.
39. Kucharewicz-Krukowska A, Slopek S. Immunogenic effect of bacteriophage in patients subjected to phage therapy. Arch Immunol Ther Exp 1987; 35:553-61.
40. Ochs HD, Davis SD, Wedgwood RJ. Immunologic responses to bacteriophage phi-X 174 in immunodeficiency diseases. J Clin Invest 1971; 50:2559-68.
41. Merril CR, Biswas B, Carlton R, et al. Long-circulating bacteriophage as antibacterial agents. Proc Natl Acad Sci U S A 1996; 93:3188-92.
42. Verma V, Harjai K, Chhibber S. Characterization of a T7-like lytic bacteriophage of Klebsiella pneumoniae B5055: a potential therapeutic agent. Curr Microbiol 2009; 59:274-81.
43. Li XY, Lin ZY, Zhu PP, Jin YF. Effect of cyclophosphamide on serum complement in mice. Zhongguo Yao Li Xue Bao 1987; 8: 79-83.
44. Pennington JE, Matthews WJ Jr, Marino JT Jr, Colten HR. Cyclophos-phamide and cortisone acetate inhibit complement biosynthesis by guinea pig bronchoalveolar macrophages. J Immunol 1979; 123: 1318-21.